Literature DB >> 16817769

Immune restoration under HAART in patients chronically infected with HIV-1: diversity of T, B, and NK immune responses.

H Le Guillou-Guillemette1, G Renier, B Vielle, P Abgueguen, J-M Chennebault, F Lunel, C Payan.   

Abstract

The aim of the study was to follow prospectively the humoral, cellular and innate immune responses under HAART and to verify if a functional restoration of the B lymphocytes could be evaluated by measuring the anti-HIV-1 IgG antibodies avidity index (AI). Eleven HIV-1 infected and immunosuppressed patients were included in the study. Viral load, naive and memory B-cells, CD4 and CD8 T-cells and NK-cells counts, and anti-HIV-1 IgG AI were determined during the follow-up (18 months). Ten patients were sustained responders under HAART and showed a quantitative restoration of the CD4 T-cell counts (+269 x 10(6)/L). The AI decreased for ten subjects (-11%, p = 0.006) but very slowly and continuously. A quantitative restoration of the humoral immune response began, mainly concerning the naive B-cells (+110 x 10(6)/L). Apart from one patient, the CD8 T-cell subset approached the reference values of healthy subjects either by decreasing or increasing their cell levels. No homogeneous evolution was described concerning the NK-cell subset, apart from trend towards increasing in patients with opportunistic infection (range, +58 to +291 x 10(6)/L). Our study, which evaluated simultaneously for the first time to our knowledge the cellular, humoral and innate immune responses showed that HAART induced a large diversity of immune restoration patterns in responder patients. However, the AI measure appears to be a weak marker to evaluate an immune restoration in chronic HIV-1 infected patients under HAART.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16817769     DOI: 10.1089/vim.2006.19.267

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  4 in total

1.  Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection.

Authors:  Vivek Naranbhai; Christina C Chang; Raveshni Durgiah; Saleha Omarjee; Andrew Lim; Mahomed-Yunus S Moosa; Julian H Elliot; Thumbi Ndung'u; Sharon R Lewin; Martyn A French; William H Carr
Journal:  AIDS       Date:  2014-03-13       Impact factor: 4.177

2.  Immunologic basis for revaccination of HIV-infected children receiving HAART.

Authors:  Kaitlin Rainwater-Lovett; William J Moss
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

3.  Induction of a Soluble Anti-HIV-1 factor (s) with IFN-γ, IL-10, and β-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture.

Authors:  José W Rodríguez; Nat O Pagan; María C Ocasio; Zilka Ríos; Luis A Cubano; Nawal M Boukli; Miguel Otero; Robert Hunter; Madhavan P Nair; Eddy Rios-Olivares
Journal:  Am J Infect Dis       Date:  2007

Review 4.  B cells in HIV infection and disease.

Authors:  Susan Moir; Anthony S Fauci
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.